Life Sciences

Accelerating the speed of innovation for patients

Telehealth emerges as critical weapon for public health officials combating the opioid epidemic

This past October, the U.S. passed a package of bills focused on confronting the nation’s opioid epidemic. Collectively known as the SUPPORT for Patients and Communities Act[1], the legislation contains a number of legal and regulatory tweaks designed to make addiction treatment more accessible. Among them is a new focus on telehealth, which will make […]

Continue reading

Success story: The Aurum Institute

The Aurum Institute needed to integrate clinical data from cross-border research sites located in several sub-Saharan African countries, each run by data managers who speak different languages and possess varied levels of experience with electronic data capture.

Continue reading

No lazy summers for Watson Health: heavy on ‘a’ – action

This past October, the U.S. passed a package of bills focused on confronting the nation’s opioid epidemic. Collectively known as the SUPPORT for Patients and Communities Act[1], the legislation contains a number of legal and regulatory tweaks designed to make addiction treatment more accessible. Among them is a new focus on telehealth, which will make […]

Continue reading

“Connected health” designed for health

Over the years, the life sciences industry has been investing in capturing and analyzing patient health information. Specifically, companies have been creating digital health applications with the goal of improving treatment and care.

Continue reading

Discover “Discovery”

I have worked with various flavors of Watson in the last 4 years, and it has taught me a lot about the need to understand bias, both in data and the interpretation of it.  In the spirit of transparency, I will be honest about my own bias – my favorite Watson Health product is Watson […]

Continue reading

ISPOR 2018 was speaking our language

“We’re all patients,” noted Dr. Michelle McMurry-Heath, a panelist in the first plenary session that kicked off ISPOR 2018, a 5-day conference devoted to health economics and outcomes research (HEOR) in Baltimore at the end of May.

Continue reading

SmartAnalyst Inc. used IBM Explorys clinical data to improve how a company markets its medications

SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the journey of more than 6,500 real-life psoriasis patients. As a result, SmartAnalyst’s customer, a pharmaceutical company, is changing the way it communicates with patients and doctors.

Continue reading

SmartAnalyst Inc. used the IBM Explorys clinical data set to boost physician adoption of certain cancer treatments

The IBM® Watson Health™ team helped SmartAnalyst use IBM Explorys® Offerings for Life Sciences to compare treatment patterns and time-to-event outcomes for almost 2,000 real world lines of therapy for multiple myeloma.

Continue reading

Generating Insights with Confidence – Agile Advanced Analytics on Longitudinal Health Records

This webinar replay reviews how the IBM Global Business Services (GBS) team generated actionable insights by applying machine learning on integrated EHRs (IBM Explorys clinical data set) and has thus helped life science companies tailor their business strategies and achieve research breakthroughs.

Continue reading

IBM Explorys Offerings for Life Sciences: Cohort Analysis

Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights.

Continue reading

Watson for Drug Discovery Identifies Proteins Associated with Cardiovascular Disease

Heart attack and stroke are 2 of the top 10 causes of death worldwide. Identifying the proteins involved in each of them is the beginning of a journey to understanding how these diseases develop. In a novel experiment presented at the American Heart Association Scientific Sessions on November 12, 2017, and published in a supplement […]

Continue reading

Insights brief: Advancing outcomes-based contracting

In this brief, we share insights on challenges in managing outcomes-based contracts (OBCs) with health plans today and solutions to address these challenges, based on our conversations with more than a dozen life sciences companies.

Continue reading